These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19435668)

  • 1. Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2.
    Perlikowska R; Gach K; Fichna J; Toth G; Walkowiak B; do-Rego JC; Janecka A
    Bioorg Med Chem; 2009 Jun; 17(11):3789-94. PubMed ID: 19435668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2.
    Perlikowska R; Piekielna J; Mazur M; Koralewski R; Olczak J; do Rego JC; Fichna J; Modranka J; Janecki T; Janecka A
    Bioorg Med Chem; 2014 Sep; 22(17):4803-9. PubMed ID: 25047937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
    Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
    J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2.
    Staniszewska R; Fichna J; Gach K; Toth G; Poels J; Vanden Broeck J; Janecka A
    Chem Biol Drug Des; 2008 Jul; 72(1):91-4. PubMed ID: 18564215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
    Fichna J; do-Rego JC; Janecki T; Staniszewska R; Poels J; Broeck JV; Costentin J; Schiller PW; Janecka A
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1350-3. PubMed ID: 18207400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.
    Liu HM; Liu XF; Yao JL; Wang CL; Yu Y; Wang R
    J Pharmacol Exp Ther; 2006 Oct; 319(1):308-16. PubMed ID: 16803861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.
    Shimoyama M; Shimoyama N; Zhao GM; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2001 Apr; 297(1):364-71. PubMed ID: 11259564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
    Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
    Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2.
    Perlikowska R; Fichna J; Wyrebska A; Poels J; Vanden Broeck J; Toth G; Storr M; do Rego JC; Janecka A
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):106-13. PubMed ID: 19874287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
    Perlikowska R; Piekielna J; Gentilucci L; De Marco R; Cerlesi MC; Calo G; Artali R; Tömböly C; Kluczyk A; Janecka A
    Eur J Med Chem; 2016 Feb; 109():276-86. PubMed ID: 26785295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of highly potent and selective endomorphin-1 analogues containing α-methylene-β-aminopropanoic acids (map).
    Wang Y; Xing Y; Liu X; Ji H; Kai M; Chen Z; Yu J; Zhao D; Ren H; Wang R
    J Med Chem; 2012 Jul; 55(13):6224-36. PubMed ID: 22724433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of degradation on binding properties and biological activity of endomorphin 1.
    Szatmári I; Biyashev D; Tömböly C; Tóth G; Mácsai M; Szabó G; Borsodi A; Lengyel I
    Biochem Biophys Res Commun; 2001 Jun; 284(3):771-6. PubMed ID: 11396969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.
    Janecka A; Fichna J; Kruszynski R; Sasaki Y; Ambo A; Costentin J; do-Rego JC
    Biochem Pharmacol; 2005 Dec; 71(1-2):188-95. PubMed ID: 16288997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position.
    Fichna J; do-Rego JC; Kosson P; Costentin J; Janecka A
    Biochem Pharmacol; 2005 Jan; 69(1):179-85. PubMed ID: 15588726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potent μ-opioid agonists.
    Liu X; Wang Y; Xing Y; Yu J; Ji H; Kai M; Wang Z; Wang D; Zhang Y; Zhao D; Wang R
    J Med Chem; 2013 Apr; 56(7):3102-14. PubMed ID: 23477419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of opioid activities of endomorphins analogs with novel constrained C-terminus: evidence for the important role of proper spatial disposition of the third aromatic ring.
    Yu Y; Shao X; Wang CL; Liu HM; Cui Y; Fan YZ; Liu J; Wang R
    Peptides; 2007 Apr; 28(4):859-70. PubMed ID: 17276550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomorphin-1 analogs with oligoarginine-conjugation at C-terminus produce potent antinociception with reduced opioid tolerance in paw withdrawal test.
    Yuan BY; Liu WZ; Wang XF; Zhang YZ; Yang DJ; Wang CL
    Peptides; 2018 Aug; 106():96-101. PubMed ID: 30016700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline.
    Spampinato S; Qasem AR; Calienni M; Murari G; Gentilucci L; Tolomelli A; Cardillo G
    Eur J Pharmacol; 2003 May; 469(1-3):89-95. PubMed ID: 12782189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of new endomorphin analogs with enhanced central antinociception after peripheral administration.
    Liu X; Zhao L; Wang Y; Mou L; Yang J; Zhang Y; Wang D; Wang R
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5393-7. PubMed ID: 26403932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel endomorphin-1 analogs with C-terminal oligoarginine-conjugation display systemic antinociceptive activity with less gastrointestinal side effects.
    Wang CL; Qiu TT; Diao YX; Zhang Y; Gu N
    Biochimie; 2015 Sep; 116():24-33. PubMed ID: 26115815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.